The following paragraphs describe the molecular mechanisms that, in a simplified view, enable unhindered tumor cell growth, driven by constitutive NFκB and STAT3 signaling, and simultaneously preclude immune cell activation by preventing pro-inflammatory NFκB via STAT3-driven mechanisms (Figure 7). This evidence concerns the gene NFKB1 and neoplasm.